Status:
UNKNOWN
Markers of Prognosis and Response to Therapy in Patients With Metastatic Brain Tumors Undergoing Stereotactic Radiosurgery (SRS)
Lead Sponsor:
Swedish Medical Center
Conditions:
Metastatic Brain Tumor
Eligibility:
All Genders
19-80 years
Brief Summary
This registry study will evaluate patients with metastatic brain tumors undergoing, or having undergone, stereotactic radiosurgery (SRS) at Swedish Medical Center. Clinical outcomes will be evaluated ...
Eligibility Criteria
Inclusion
- Adult patients (\>18 yo) with a pathological diagnosis of metastatic brain cancer
- Participants must have \>4 tumors felt to require stereotactic radiosurgery
- Karnofsky scale of \> 70 at the time of initial treatment
- Age \< 80
Exclusion
- Karnofsky scale \<70
- Age \> 80
- Inability to undergo MR imaging studies
Key Trial Info
Start Date :
January 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01908179
Start Date
January 1 2013
Last Update
July 25 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Swedish Medical Center
Seattle, Washington, United States, 98122